Copyright © Inderes 2011 - present. All rights reserved.

Midsona

11,15 SEK

-5,11 %

Mindre end 1K følgere

MSON B

NASDAQ Stockholm

Food & Beverage

Consumer Goods & Services

-5,11 %
+29,35 %
+31,49 %
+30,87 %
+34,66 %
+25,85 %
+24,30 %
-86,53 %
-53,58 %

Midsona operates in the health and wellness industry and focuses on the manufacture and distribution of dietary supplements and health products. The company's products are aimed at individuals and retailers looking for healthy alternatives. The business is global with a primary presence in Europe. Midsona was founded in 1892 and is headquartered in the city of Malmö, Sweden.

Læs mere
Markedsværdi
1,62 mia. SEK
Aktieomsætning
3,47 mio. SEK
Omsætning
3,63 mia.
EBIT %
1,6 %
P/E
159,29
Udbytteafkast, %
1,97 %
Omsætning og EBIT-margin

Omsætning mia.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
24.4
2026

Delårsrapport Q1'26

6.5
2026

Generalforsamling '26

7.5
2026

Årligt udbytte

ViserAlle indholdstyper
Eksterne analyser

Midsona: Brighter days ahead - ABG

* Underlying performance indicative of a brighter '26e * '26e-'27e adj. EBITA up 5% * Trading at NTM EV/EBITA of 8x Solid underlying performance boosted by NRIs Q4 came in above expectations on all key items, but was especially strong on adj. EBIT (29...

Midsona

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Eksterne analyser

Midsona: Closing the year in style - ABG

* Adj. EBIT 29% above estimates at SEK 47m * '26e could bring both organic and structural growth * Consensus EBIT revisions likely up h.s.d. Q4'25 report The Q4 report was materially better than expected on adj. EBIT. Sales amounted to SEK 933m (2% vs...

Midsona
Eksterne analyser

Midsona: Persistent earnings despite soft sales - ABG

* Q4e: soft growth, but margins supported by restructuring programme* Estimate cuts on FX and product mix* Trading at '26e EV/EBITA of ~7.5xWhat to expect in Q4'25eWe anticipate -1% y-o-y organic growth in Q4'25e, implying sales of SEK 918m and adj. ...

Midsona
Eksterne analyser

Midsona: Feedback from ABGSC Investor Days - ABG

* Strong potential for margin improvements* Short term priorities presented* Favourable sales mix is the key driver for 8% margin Well-positioned in a recovering market Today, we welcomed Midsona's new CEO, Henrik Hjalmarsson, to ABGSC's Investor Days...

Midsona
Eksterne analyser

Midsona: A step in the right direction - ABG

* '25e-'27e adj. EBITA up 12-5%* Encouraging efficiency improvements and strategic initiatives* Trading at NTM EV/EBITA of ~8x A solid quarter despite sales headwinds The Q3 report was stronger than we had expected on all key line items, as sales and...

Midsona
Eksterne analyser

Midsona: Solid Q3 and cost savings bode well for '26e - ABG

* 2% sales beat & adj. EBIT SEK 45m vs. ABGSCe 29m* Announces restructuring programme of SEK 20m p.a.* Consensus estimate revisions likely in positive low teens Q3'25 report The Q3 report was above expectations on sales and adj. EBIT. Sales amounted ...

Midsona
Eksterne analyser

Midsona: Still impacted by the factory fire - ABG

* Q3e: soft growth but GM improvements* Minor estimate cuts on FX and product mix* Trading at '26e EV/EBITA of ~7xWhat to expect in Q3'25eWe anticipate -2% y-o-y organic growth in Q3'25e, implying sales of SEK 879m and EBIT of SEK 29m, for a margin of...

Midsona
Eksterne analyser

Midsona: External factors weigh on performance - ABG

Softer across the board The Q2 report was softer than we had expected with regard to all key line items, as sales and EBIT were respectively 5% and ~80% below our expectations. The organic growth rate was adversely impacted by the ongoing change in the...

Midsona
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.